Hims&Hers Hlth-A (HIMS)
$45.89
0.80 (1.74%)
HIMS Stock Quote Delayed 30 Minutes
HIMS Stock Earnings: Hims & Hers Health Beats EPS, Beats Revenue for Q2 2024
HIMS stock results show that Hims & Hers Health beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$41.34
Market Cap
10.02B
PE Ratio
86.21
EPS
0.5323
Volume (Avg. Vol.)
29.81M
Day's Range
$40.14 - $45.31
52-Week Range
$11.20 - $72.98
Dividend & Yield
N/A (N/A)
HIMS Stock Predictions, Articles, and Hims&Hers Hlth-A News
3 Stocks Poised to 10X in the Next 5 Years
Explore the potential 10X stocks that could revolutionize the investment strategy in the healthcare and consumer discretionary sectors.
Short Seller Hunterbrook Slams Hims & Hers (HIMS) Stock in New Report
HIMS stock is trading lower after Hunterbrook Media published a short report on the company, taking issue with its compounded GLP-1 drug.
HIMS Stock Alert: Hims & Hers Shares Rocket on Weight Loss Injections
HIMS stock is catching a bid after Hims & Hers announced that it would begin providing access to GLP-1 weight-loss injections.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start the day with a breakdown of the biggest pre-market stock movers traders need to keep an eye on for Tuesday!
HIMS Stock Earnings: Hims & Hers Health Beats EPS, Beats Revenue for Q1 2024
HIMS stock results show that Hims & Hers Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
3 Disruptive Healthcare Stocks That Could Surge 1000% By 2028
Discover the untapped potential of disruptive healthcare stocks, capitalizing on transformative healthcare technology and delivery.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers as we check out all of the hottest news affecting shares on Tuesday morning!
